← Back

Omada Health, Inc. Common Stock

Omada Health, Inc., together with its subsidiary Physera, Inc., provides virtual care programs in the United States. Its offerings include cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program for musculoskeletal conditions; support programs for members taking glucagon-like peptide-1 agonists within its cardiometabolic program; weight management programs; and various behavioral health support programs. The company serves employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. Incorporated in 2011, it is headquartered in South San Francisco, California.

Country
Price · split & dividend adjusted
News & notes moving OMDA
OMDA

Omada Health Reports Record Q2 Revenue of $88 Million, Up 43%

Omada Health reported record second-quarter revenue of $88 million, a 43% year-over-year increase, alongside a record gross margin of 74% and adjusted EBITDA of $10.8 million. CFO Steve Cook discussed a leadership change announced the prior week, with co-founder and CEO Sean transitioning to executive chairman and President Wei Shao becoming CEO. The company is broadening its cardiometabolic platform through expanded health-plan and channel partnerships, including an additional 1.5 million covered lives via Health Care Service Corporation. About 15% of members were in GLP-1-related programs, and a prescribing offering through Optum is planned for next year. Cook said the midpoint of Omada's current revenue guidance implies 30% growth.
MarketBeat·38dRead more →
OMDA

Omada Health CEO Sean Duffy Sells 17,258 Shares Under Trading Plan

Omada Health CEO Sean Duffy sold 17,258 shares of the company in multiple open-market transactions from June 24 through June 26, 2026, according to an SEC filing. The sale, executed under a pre-established 10b5-1 trading plan adopted on March 13, 2026, was valued at approximately $342,000 based on a weighted average price of $19.82 per share. Following the transactions, Duffy's direct holdings stand at 394,603 shares, with an additional 851,659 shares held indirectly, reducing his beneficial ownership from 0.6928% to 0.6638%. Omada Health, which provides digital care programs for chronic conditions, held its initial public offering in June 2025 at $19 per share, and the stock closed at $20.89 on June 26, 2026.
The Motley Fool·78dRead more →
OMDA

Omada Health Shares Jump 10.5% on Strong Volume

Omada Health shares surged 10.5% to $20.89 in the last trading session on higher-than-average volume. The gain was fueled by optimism following the company's presentation at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, where it highlighted crossing 1 million total members for the first time since inception, with strong enrollment across GLP-1 services and cardiometabolic offerings. The company is expected to report quarterly earnings of $0.05 per share, a year-over-year increase of 155.6%, on revenues of $80.93 million, up 31.9%. Despite the price jump, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days, and the stock carries a Zacks Rank of 3, or Hold.
Zacks Investment Research·81dRead more →